FDA Adverse Event Injury Summary report: N

PULSE GEN MODEL 103

MDR report key: 2854196 · Received December 3, 2012

Report

Report Number
1644487-2012-03169
Event Type
Injury
Date Received
December 3, 2012
Date of Event
September 18, 2012
Report Date
November 8, 2012
Manufacturer
CYBERONICS, INC.
Product Code
LYJ
PMA / PMN Number
P970003
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

.

Description of Event or Problem · 1

ON (B)(6) 2012, CLINIC NOTES WERE RECEIVED FROM A VNS TREATING PHYSICIAN DATED (B)(6) 2012, WHICH INDICATED THAT THE PATIENT'S SEIZURE ACTIVITY HAS WORSENED SLIGHTLY. THE MAJORITY OF THE PATIENT'S SEIZURES ARE DROP SEIZURES. IT WAS REPORTED THAT THE VNS WAS INTERROGATED AND THE BATTERY WAS LOW. THE PATIENT WAS REFERRED FOR BATTERY REPLACEMENT. ALTHOUGH SURGERY IS LIKELY, IT HAS NOT OCCURRED TO DATE. GOOD FAITH ATTEMPTS FOR FURTHER INFORMATION FROM THE NURSE PRACTITIONER HAVE BEEN MADE BUT HAVE BEEN UNSUCCESSFUL.

Description of Event or Problem · 1

ADDITIONAL INFORMATION WAS RECEIVED ON (B)(6) 2012 WHEN IT WAS REPORTED THAT THE LEAD IMPEDANCE AFTER SURGERY WAS "OK" AND WAS A VALUE OF 2272OHMS.

Description of Event or Problem · 1

ADDITIONAL INFORMATION WAS RECEIVED ON (B)(6) 2012, WHEN IT WAS REPORTED THAT THE PATIENT HAD HIS GENERATOR REPLACED DUE TO END OF SERVICE THAT DAY. PRE-OPERATIVE DIAGNOSTICS WERE PERFORMED WHICH SHOWED OUTPUT=OK/LEAD IMPEDANCE=OK/IMPEDANCE VALUE=2356OHMS/NEOS=YES. THE PHYSICIAN REPORTED THAT THERE WAS NOT AN INCREASE IN SEIZURES FROM (B)(6) 2012; THE PATIENT'S SEIZURES WERE STABLE. THE PHYSICIAN FURTHER SAID THAT THE SEIZURES WERE NOT RELATED TO VNS BUT THERE WAS NO INCREASE IN SEIZURES REPORTED. THE EXPLANTED GENERATOR COULD NOT BE RETURNED FOR PRODUCT ANALYSIS AS THE HOSPITAL DOES NOT RETURN EXPLANTED DEVICES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PULSE GEN MODEL 103 GENERATOR LYJ CYBERONICS, INC. 103 1952

Patients

Seq Age Sex Outcome Treatment
1 16 YR Other